August 10, 2026

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a Potential 102.59% Upside in the Booming RNA Therapeutics Market

Atrium Therapeutics, Inc. (NASDAQ: RNA), a burgeoning player in the biotechnology sector, is capturing investor attention with its innovative approach to RNA therapeutics targeting cardiomyopathies. With..

Guardant Health, Inc. (GH) Stock Analysis: Assessing Growth Potential with a 15.32% Upside

Guardant Health, Inc. (GH), a leader in precision oncology, is garnering attention from investors with a robust growth trajectory and an enticing potential upside of 15.32%..

BrightSpring Health Services (BTSG): Analyst Ratings Suggest a 26% Upside Potential for this Healthcare Powerhouse

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, is attracting significant investor attention, thanks to its robust growth trajectory and bullish analyst..

Cytokinetics, Incorporated (CYTK) Stock Analysis: 41.81% Potential Upside and Strong Buy Ratings

Investors seeking opportunities in the biotechnology sector might find Cytokinetics, Incorporated (NASDAQ: CYTK) an intriguing prospect. This South San Francisco-based biopharmaceutical company is dedicated to pioneering..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovations with a 15.99% Upside Potential

TransMedics Group, Inc. (TMDX) is at the forefront of revolutionizing the organ transplant industry, with a focus on enhancing the viability and success rates of organ..

Baxter International Inc. (BAX) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Price Dynamics

Investors eyeing the healthcare sector should pay close attention to Baxter International Inc. (NYSE: BAX), a well-established player in the medical instruments and supplies industry. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: Potential 87.70% Upside with Innovative Vaccine Pipeline

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, is gaining significant attention from investors, driven by its robust vaccine innovation pipeline and promising market..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech with Strong Revenue Growth and Substantial Upside Potential

In the dynamic world of biotechnology, TG Therapeutics, Inc. (NASDAQ: TGTX) stands out with its robust pipeline and impressive growth metrics. With a market capitalization of..

Waters Corporation (WAT) Stock Analysis: A Strong Buy with a 7% Upside Potential

Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment opportunity for individual investors. With its..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Strong Potential Upside with Robust Analyst Ratings

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a formidable player in the healthcare sector, specializes in medical devices and boasts a significant market cap of $18.42 billion...

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Analyzing the 31.63% Potential Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing the attention of investors with its significant 31.63% potential upside. This commercial-stage biopharmaceutical..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 20% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, particularly within the medical care facilities industry. With a market cap of $3.56 billion,..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Analyzing a 22.4% Potential Upside for This Biotech Innovator

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a key player in the biotechnology sector focusing on rare neuroendocrine diseases, has caught the eye of investors with its innovative..

Oscar Health, Inc. (OSCR) Stock Analysis: Impressive Revenue Growth and What It Means for Investors

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, continues to catch the eye of investors with its impressive 70.40% revenue growth...

argenx SE (ARGX) Stock Analysis: Unlocking a 25% Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology industry, is making waves with its innovative therapies targeting autoimmune diseases. With a market capitalization of..

Bio-Rad Laboratories (BIO) Stock Analysis: Exploring a Potentially Overvalued Healthcare Giant

Bio-Rad Laboratories, Inc. (NYSE: BIO), a formidable player in the medical devices industry, has captured the attention of investors with its stock price soaring to $352.47,..

Zoetis Inc. (ZTS) Investor Outlook: Analyzing a Potential 43% Upside in the Healthcare Sector

Zoetis Inc. (NYSE: ZTS) remains a prominent player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic products. With a..

Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) has emerged as a formidable player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With..

Glaukos Corporation (GKOS) Stock Analysis: Target Price Insights and Growth Prospects

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, has recently captured significant attention from investors due to..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) is making waves in the biotechnology sector with its promising pipeline of clinical-stage products and innovative delivery platforms. As a United..

Search

Funds

August 10, 2026

Search

Funds

August 10, 2026

FTSE 100

Funds